$GTHX G1 Therapeutics, Inc. Insider Trading Week 21/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. in week 21/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | C | 0.00 | 2,524,233 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Option Exercise | C | 0.00 | 6,893,224 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Buy | P | 15.00 | 300,000 | 4,500,000 | 3,439,151 | 3.1 M to 3.4 M (+9.56 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | ESHELMAN FREDRIC N | Director | Buy | C | 0.00 | 3,139,151 | 0 | 3,139,151 | 0 to 3.1 M |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Strum Jay | Chief Scientific Of ... | Buy | C | 0.00 | 16,666 | 0 | 58,569 | 41.9 K to 58.6 K (+39.77 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | SHAFFER CHRISTY L | Director | Option Exercise | C | 0.00 | 126,212 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | SHAFFER CHRISTY L | Director | Option Exercise | C | 0.00 | 172,331 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | SHAFFER CHRISTY L | Director | Buy | C | 0.00 | 99,513 | 0 | 99,513 | 0 to 99.5 K |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Option Exercise | C | 0.00 | 8,271 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Director | Buy | C | 0.00 | 2,757 | 0 | 58,282 | 55.5 K to 58.3 K (+4.97 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Option Exercise | C | 0.00 | 302,908 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Buy | P | 15.00 | 20,000 | 300,000 | 120,969 | 101 K to 121 K (+19.81 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Buy | C | 0.00 | 100,969 | 0 | 100,969 | 0 to 101 K |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 673,128 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 2,412,628 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 7,142,857 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 15.00 | 75,000 | 1,125,000 | 3,484,536 | 3.4 M to 3.5 M (+2.20 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 3,409,536 | 0 | 3,409,536 | 0 to 3.4 M |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Eshelman Ventures, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,524,233 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Eshelman Ventures, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,893,224 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Eshelman Ventures, LLC | 10% Owner | Buy | P | 15.00 | 300,000 | 4,500,000 | 3,439,151 | 3.1 M to 3.4 M (+9.56 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Eshelman Ventures, LLC | 10% Owner | Buy | C | 0.00 | 3,139,151 | 0 | 3,139,151 | 0 to 3.1 M |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 1,009,693 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 2,584,959 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 6,568,527 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Option Exercise | C | 0.00 | 1,318,681 | 0 | 0 | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,861,797 | 3.7 M to 3.9 M (+3.58 %) |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | C | 0.00 | 99,513 | 0 | 99,513 | 0 to 99.5 K |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | C | 0.00 | 212,419 | 0 | 212,419 | 0 to 212.4 K |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Buy | C | 0.00 | 3,728,464 | 0 | 3,728,464 | 0 to 3.7 M |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | C | 0.00 | 1,682,822 | 0 | 0 | ||
| May 24 2017 | GTHX | G1 Therapeutics, I ... | RA CAPITAL MANAGEMENT, LLC | Option Exercise | C | 0.00 | 5,169,916 | 0 | 0 | ||
| May 24 2017 | GTHX | G1 Therapeutics, I ... | RA CAPITAL MANAGEMENT, LLC | Buy | P | 15.00 | 400,000 | 6,000,000 | 2,684,244 | 2.3 M to 2.7 M (+17.51 %) | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | RA CAPITAL MANAGEMENT, LLC | Buy | C | 0.00 | 560,940 | 0 | 2,284,244 | 1.7 M to 2.3 M (+32.55 %) | |
| May 24 2017 | GTHX | G1 Therapeutics, I ... | RA CAPITAL MANAGEMENT, LLC | Buy | C | 0.00 | 1,723,304 | 0 | 1,723,304 | 0 to 1.7 M |